Khaled Hassan, MD, MS

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

Dr. Hassan graduated from American University of Beirut (AUB), Lebanon and received his medical degree from Kursk State Medical University, Russia. His interest in research lead him to pursue a Master’s Degree in Physiology at AUB and a postdoctoral fellowship at MD Anderson Cancer Center, Houston. He then completed his Internal Medicine Residency at Good Samaritan Hospital in Baltimore and joined University of Michigan, Ann Arbor for a fellowship in Hematology/Oncology. He was recruited as a physician-scientist by University of Michigan and became Assistant professor in 2012. His clinical and research efforts are in lung cancer.Dr. Hassan’s research focuses on mechanisms of treatment resistance in lung cancer. 

His research has been funded by the NIH/NCI, IASLC, among others. He has published seminal manuscripts addressing lung cancer stem cells and cytosine deamination role in resistance to chemotherapy and targeted EGFR treatment.